PMID:17893885

Citation	Ploplis, VA, Tipton, H, Menchen, H and Castellino, FJ (2007) A urokinase-type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice. J. Pathol. 213:266-74
Abstract	The interaction of urokinase-type plasminogen activator (uPA) and its receptor, uPAR, on cell surfaces facilitates the generation of cell-bound plasmin, thus allowing cells to establish a proteolytic front that enables their migration through protein barriers. This complex also activates cell signalling pathways that influence cell functions. Clinical studies have identified uPA as an indicator of poor overall survival in patients with colorectal cancer. In the current study, a mouse model of colon cancer, Apc(Min/+), with an additional deficiency of uPA (Apc(Min/+)/Plau-/-) was used to determine the effects of uPA on tumour initiation and growth. Utilizing this model, it was found that the number of tumours was diminished in these mice relative to Apc(Min/+) mice, which correlated with the decreased leukocyte infiltration in the tumours. However, tumour growth was not impeded in Apc(Min/+)/Plau-/- mice, and proliferation and tumour vascularization were, in fact, enhanced in Apc(Min/+)/Plau-/- mice. These latter effects are consistent with a mechanism involving up-regulation of COX-2 expression and Akt pathway activation in Apc(Min/+)/Plau-/- mice. The results from this study suggest that uPA plays dual and opposing roles in regulating lesion development: one early, during the transition from normal epithelia to dysplastic lesions, and another later during tumour growth.
Links	PubMed Online version:10.1002/path.2236
Keywords	Adenomatous Polyposis Coli/genetics; Adenomatous Polyposis Coli/immunology; Adenomatous Polyposis Coli/pathology; Animals; Blood Coagulation; Cell Proliferation; Cyclooxygenase 2/analysis; Dinoprostone/analysis; Gastrointestinal Neoplasms/genetics; Gastrointestinal Neoplasms/immunology; Gastrointestinal Neoplasms/pathology; Genes, APC; Immunohistochemistry; Intestines/immunology; Leukocytes/immunology; Mice; Mice, Mutant Strains; Models, Animal; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt/analysis; Time Factors; Urokinase-Type Plasminogen Activator/blood; Urokinase-Type Plasminogen Activator/deficiency; Urokinase-Type Plasminogen Activator/genetics
edit table

Annotations

Gene product	Qualifier	GO ID	GO term name	Evidence Code	with/from	Aspect	Notes	Status
edit table

References

See Help:References for how to manage references in GONUTS.